Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anticoagulant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05471830
What this trial is testing

An Observational Study (Called RETAF-PS) Using a Patient Survey to Learn More About Treatment Outcomes in Patients With Irregular and Often Rapid Heartbeat (Atrial Fibrillation) Treated With Apixaban in a Real World Setting

Who this might be right for
Prevention of Thromboembolic EventsAtrial Fibrillation
Bayer 600
Large-scale testing (Phase 3)Study completedNCT03395639
What this trial is testing

Edoxaban for Prevention of Blood Vessels Being Blocked by Clots (Thrombotic Events) in Children at Risk Because of Cardiac Disease

Who this might be right for
Cardiac Disease
Daiichi Sankyo 168
Post-approval studies (Phase 4)Study completedNCT01354704
What this trial is testing

Echo-Doppler Assessment of the Occurrence of Asymptomatic DVT in Orthopedic Replacement Surgery Under Enoxaparin

Who this might be right for
Deep Vein ThrombosisVenous ThrombosisAdverse Effect of Anticoagulants
Les Laboratoires des Médicaments Stériles 153
Not applicableStudy completedNCT02777047
What this trial is testing

Coordination of Oral Anticoagulant Care at Hospital Discharge

Who this might be right for
Anticoagulants
St. Joseph's Healthcare Hamilton 56
Not applicableStudy completedNCT05224388
What this trial is testing

Evaluating Dose Regimen of Intravenous Unfractionated Heparin and Low Molecular Weight Heparin in Critical Ill Patients Versus Critical Ill COVID-19 Patients Using Anti-Xa Levels.

Who this might be right for
COVID-19Deep Vein ThrombosisAnticoagulants and Bleeding Disorders+1 more
University Hospital, Ghent 813
Not applicableStudy completedNCT02533960
What this trial is testing

Registry of Acute Stroke Under Novel Oral Anticoagulants - Prime

Who this might be right for
Ischemic StrokeIntracerebral HemorrhageOral Anticoagulation+2 more
University Hospital Heidelberg 3,832
Not applicableUnknownNCT03785080
What this trial is testing

Non-warfarin Oral AntiCoagulant Resumption After Gastrointestinal Bleeding in Atrial Fibrillation Patients

Who this might be right for
Upper Gastrointestinal Bleeding
Chinese University of Hong Kong 552
Not applicableActive Not RecruitingNCT03892824
What this trial is testing

Carotid Artery Implant for Preventing Stroke in Atrial Fibrillation Patients Taking Oral Anticoagulants

Who this might be right for
Atrial FibrillationStroke
Javelin Medical 100
Not applicableUnknownNCT04671160
What this trial is testing

Impact of Continuous Veno-venous Hemodiafiltration on Efficacy of Administration of Prophylactic Doses of Enoxaparin or Fondaparinux in Critically Ill Patients.

Who this might be right for
Assessment of Activity of Anti-Xa Factor in Patients Treated With Continuous Veno-venous Hemodiafiltration Receiving Anticoagulant Prophylaxis
Medical University of Gdansk 80
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06729034
What this trial is testing

Direct Oral Anticoagulants in Patients with Painful Venous Malformations with Localized Intravascular Coagulation

Who this might be right for
Venous Malformation, Low FlowAnticoagulants
Oslo University Hospital 20
Post-approval studies (Phase 4)UnknownNCT04628884
What this trial is testing

Strategies for Protamine Dosing After Anticoagulation in Cardiovascular Surgery

Who this might be right for
Anticoagulant Antagonist Toxicity
Fundación Clínica Shaio 136
Large-scale testing (Phase 3)Study completedNCT00403767
What this trial is testing

An Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial Fibrillation

Who this might be right for
Atrial FibrillationStrokeEmbolism
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 14,269
Not applicableStudy completedNCT02559232
What this trial is testing

An Observational Cross-sectional Study Evaluating the Use of Re-sources and the Sociodemographic and Clinical Characteristics of Patients Diagnosed With Non-valvular Atrial Fibrillation With a Risk of Stroke or Systemic Embolism on Anticoagulant Therapy and Treated in Primary Care Centers

Who this might be right for
StrokePrevention and ControlAtrial Fibrillation
Bayer 247
Not applicableStudy completedNCT04412304
What this trial is testing

Anticoagulant Therapy and 28-days Mortality in Critically Ill COVID-19 Patients

Who this might be right for
Covid-19Thromboembolic EventsBleeding
Karolinska Institutet 166
Not applicableStudy completedNCT02734316
What this trial is testing

Management of Direct Oral Anti-Coagulants (DOACs) for Gastrointestinal Endoscopy Procedures

Who this might be right for
Anticoagulant Disorders
Valduce Hospital 531
Not applicableStudy completedNCT03182829
What this trial is testing

In Vitro Diagnostic Test for DOAC in Urine

Who this might be right for
Anticoagulant Therapy
Doasense GmbH 880
Not applicableStudy completedNCT03264937
What this trial is testing

Social-software iMproving wARfarin Therapy

Who this might be right for
Anticoagulants Causing Adverse Effects in Therapeutic UsePatient Compliance
Wuhan Asia Heart Hospital 735
Not applicableUnknownNCT03879473
What this trial is testing

Direct Oral Anticoagulant Management for Cardiac Device Implantation

Who this might be right for
Anticoagulant, Perioperative
Institut Necker Enfants Malades 680
Not applicableStudy completedNCT05065502
What this trial is testing

MIDAS Cluster Randomized Controlled Trial of Implementation Strategies to Optimize Use of Medications in VA Clinical Settings

Who this might be right for
PolypharmacyInsomniaAnticoagulants
VA Office of Research and Development 24
Post-approval studies (Phase 4)Active Not RecruitingNCT07185295
What this trial is testing

Short-term Interruption Versus Continuous Anticoagulation in Colorectal Polypectomy

Who this might be right for
Anticoagulated Patients
Outcomes'10 481
Next Page